Intercept Pharmaceuticals, Inc...

NASDAQ: ICPT
$47.80
+$0.57 (+1.2%)
Real time price as of August 4, 2020 11:15 am EDT
  Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see numerous waves of selling in...
The top analyst upgrades, downgrades and initiations seen on Tuesday included Boston Scientific, Etsy, General Electric, Morgan Stanley, SeaWorld, Skechers, Shopify, Square and Tesla.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
We screened our 24/7 Wall St. research database for hot biotech ideas and found four companies that are offering big upside for aggressive accounts. All are rated Buy and have the potential to...
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two weeks to start the year.
These four momentum biotech plays still have solid upside to the Jefferies price targets and would be solid additions to aggressive accounts with higher risk tolerance.
Windstream, Uniti Group, Intercept Pharmaceuticals, and Genocea Biosciences all posted new 52-week lows on Wednesday.
Versartis, Intercept Pharma, Kroger, and Mattel all posted new 52-week lows on Friday.
Kroger, Bed Bath & Beyond, Intercept Pharmaceuticals, and Mattel all posted new 52-week lows on Thursday.
As we have said before, updates from the FDA have the potential to make or break a company. In this case it seems like a mild setback, but further complications could prove to be catastrophic.
The top analyst upgrades, downgrades and other research calls from Wednesday include Biogen, Electronic Arts, Gap, Intuit, Johnson & Johnson, 3M, Intercept Pharmaceutical and AutoZone.